{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:49:21Z","timestamp":1784969361058,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proteolytic cleavage of proglucagon by prohormone convertase 2 (PC2) is required for islet \u03b1 cells to generate glucagon. However, the regulatory mechanisms underlying this process remain largely unclear. Here, we report that SEL1L-HRD1 endoplasmic reticulum (ER)-associated degradation (ERAD), a highly conserved protein quality control system responsible for clearing misfolded proteins from the ER, plays a key role in glucagon production by regulating turnover of the nascent proform of the PC2 enzyme (proPC2). Using a mouse model with SEL1L deletion in proglucagon-expressing cells, we observe a progressive decline in stimulated glucagon secretion and a reduction in pancreatic glucagon content. Mechanistically, we find that endogenous proPC2 is a substrate of SEL1L-HRD1 ERAD, and that degradation of misfolded proPC2 ensures the maturation of activation-competent proPC2 protein in the ER. Here, we identify ERAD as a regulator of PC2 biology and an essential mechanism for maintaining \u03b1 cell function.<\/jats:p>","DOI":"10.1038\/s41467-026-69928-6","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:04:08Z","timestamp":1772060648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SEL1L-HRD1 ER-associated degradation facilitates prohormone convertase 2 maturation and glucagon production in islet \u03b1 cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Wenzhen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2474-4944","authenticated-orcid":false,"given":"Linxiu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-0827","authenticated-orcid":false,"given":"Xianwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3836-3651","authenticated-orcid":false,"given":"Rohit","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Pederson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-4820","authenticated-orcid":false,"given":"Xiaoqiong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1414-610X","authenticated-orcid":false,"given":"Liangguang Leo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-4132","authenticated-orcid":false,"given":"Hannah","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9812-1676","authenticated-orcid":false,"given":"Chengyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-8799","authenticated-orcid":false,"given":"Peter","family":"Arvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-3278","authenticated-orcid":false,"given":"Darleen A.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-170X","authenticated-orcid":false,"given":"Iris","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-0184","authenticated-orcid":false,"given":"Ling","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-4219","authenticated-orcid":false,"given":"Rachel Byerley","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"69928_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI60016","volume":"122","author":"RH Unger","year":"2012","unstructured":"Unger, R. H. & Cherrington, A. D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J. Clin. Invest. 122, 4\u201312 (2012).","journal-title":"J. Clin. Invest."},{"key":"69928_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2337\/dbi19-0004","volume":"69","author":"B Finan","year":"2020","unstructured":"Finan, B., Capozzi, M. E. & Campbell, J. E. Repositioning glucagon action in the physiology and pharmacology of diabetes. Diabetes 69, 532\u2013541 (2020).","journal-title":"Diabetes"},{"key":"69928_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1152\/physrev.1976.56.4.778","volume":"56","author":"RH Unger","year":"1976","unstructured":"Unger, R. H. & Orci, L. Physiology and pathophysiology of glucagon. Physiol. Rev. 56, 778\u2013826 (1976).","journal-title":"Physiol. Rev."},{"key":"69928_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00400639","volume":"38","author":"S Dinneen","year":"1995","unstructured":"Dinneen, S., Alzaid, A., Turk, D. & Rizza, R. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38, 337\u2013343 (1995).","journal-title":"Diabetologia"},{"key":"69928_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/dom.13202","volume":"20","author":"J Pettus","year":"2018","unstructured":"Pettus, J. et al. Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: a randomized controlled trial. Diab Obes. Metab. 20, 1302\u20131305 (2018).","journal-title":"Diab Obes. Metab."},{"key":"69928_CR6","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41591-022-02011-x","volume":"28","author":"J Pettus","year":"2022","unstructured":"Pettus, J. et al. Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat. Med 28, 2092\u20132099 (2022).","journal-title":"Nat. Med"},{"key":"69928_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.isci.2019.05.030","volume":"16","author":"R Wei","year":"2019","unstructured":"Wei, R. et al. Antagonistic glucagon receptor antibody promotes \u03b1-cell proliferation and increases \u03b2-cell mass in diabetic mice. Iscience 16, 326\u2013339 (2019).","journal-title":"Iscience"},{"key":"69928_CR8","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1210\/me.2009-0296","volume":"23","author":"Y Hayashi","year":"2009","unstructured":"Hayashi, Y. et al. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells. Mol. Endocrinol. 23, 1990\u20131999 (2009).","journal-title":"Mol. Endocrinol."},{"key":"69928_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling, R. W. et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. USA. 100, 1438\u20131443 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"69928_CR10","first-page":"1127","volume":"25","author":"B Svendsen","year":"2018","unstructured":"Svendsen, B. et al. Insulin secretion depends on intra-islet glucagon signaling. CellReports 25, 1127\u20131134.e1122 (2018).","journal-title":"CellReports"},{"key":"69928_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1172\/jci.insight.126742","volume":"4","author":"ME Capozzi","year":"2019","unstructured":"Capozzi, M. E. et al. \u03b2 cell tone is defined by proglucagon peptides through cAMP signaling. JCI Insight 4, 66 (2019).","journal-title":"JCI Insight"},{"key":"69928_CR12","doi-asserted-by":"publisher","unstructured":"El, K., Capozzi, M. E. & Campbell, J. E. Repositioning the Alpha Cell in Postprandial Metabolism. Endocrinology 161 https:\/\/doi.org\/10.1210\/endocr\/bqaa169 (2020).","DOI":"10.1210\/endocr\/bqaa169"},{"key":"69928_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1152\/physrev.00013.2014","volume":"95","author":"DA Sandoval","year":"2015","unstructured":"Sandoval, D. A. & D\u2019Alessio, D. A. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiological Rev. 95, 513\u2013548 (2015).","journal-title":"Physiological Rev."},{"key":"69928_CR14","doi-asserted-by":"publisher","first-page":"39213","DOI":"10.1074\/jbc.M003547200","volume":"275","author":"L Muller","year":"2000","unstructured":"Muller, L., Cameron, A., Fortenberry, Y., Apletalina, E. V. & Lindberg, I. Processing and sorting of the prohormone convertase 2 propeptide.  J. Biol. Chem. 275, 39213\u201339222 (2000).","journal-title":"J. Biol. Chem."},{"key":"69928_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/abbi.1998.1033","volume":"362","author":"NS Lamango","year":"1999","unstructured":"Lamango, N. S., Apletalina, E., Liu, J. & Lindberg, I. The proteolytic maturation of prohormone convertase 2 (PC2) is a pH-driven process. Arch. Biochem Biophys. 362, 275\u2013282 (1999).","journal-title":"Arch. Biochem Biophys."},{"key":"69928_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dom.13379","volume":"20","author":"Y Riahi","year":"2018","unstructured":"Riahi, Y., Israeli, T., Cerasi, E. & Leibowitz, G. Effects of proinsulin misfolding on \u03b2-cell dynamics, differentiation and function in diabetes. Diab Obes. Metab. 20, 95\u2013103 (2018).","journal-title":"Diab Obes. Metab."},{"key":"69928_CR17","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.cmet.2024.09.006","volume":"36","author":"EK Sokolowski","year":"2024","unstructured":"Sokolowski, E. K. et al. Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights. Cell Metab. 36, 2468\u20132488. e2467 (2024).","journal-title":"Cell Metab."},{"key":"69928_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/er.2007-0015","volume":"29","author":"DL Eizirik","year":"2008","unstructured":"Eizirik, D. L., Cardozo, A. K. & Cnop, M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29, 42\u201361 (2008).","journal-title":"Endocr. Rev."},{"key":"69928_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.650158","volume":"12","author":"N Shrestha","year":"2021","unstructured":"Shrestha, N., Franco, E. D., Arvan, P. & Cnop, M. Pathological \u03b2-cell endoplasmic reticulum stress in type 2 diabetes: current evidence. Front. Endocrinol. 12, 650158 (2021).","journal-title":"Front. Endocrinol."},{"key":"69928_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcdb.2020.04.006","volume":"103","author":"N Shrestha","year":"2020","unstructured":"Shrestha, N., Reinert, R. B. & Qi, L. Endoplasmic reticulum protein quality control in \u03b2 cells. Semin. Cell Dev. Biol. 103, 59\u201367 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"69928_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","volume":"24","author":"JC Christianson","year":"2023","unstructured":"Christianson, J. C., Jarosch, E. & Sommer, T. Mechanisms of substrate processing during ER-associated protein degradation. Nat. Rev. Mol. Cell Biol. 24, 777\u2013796 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"69928_CR22","doi-asserted-by":"publisher","unstructured":"Krshnan, L., van de Weijer, M. L. & Carvalho, P. Endoplasmic Reticulum-Associated Protein Degradation. Cold Spring Harb Perspect Biol 14 https:\/\/doi.org\/10.1101\/cshperspect.a041247 (2022).","DOI":"10.1101\/cshperspect.a041247"},{"key":"69928_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tcb.2016.12.002","volume":"27","author":"L Qi","year":"2017","unstructured":"Qi, L., Tsai, B. & Arvan, P. New Insights into the Physiological Role of Endoplasmic Reticulum-Associated Degradation. Trends cell Biol. 27, 430\u2013440 (2017).","journal-title":"Trends cell Biol."},{"key":"69928_CR24","doi-asserted-by":"publisher","first-page":"E582","DOI":"10.1073\/pnas.1318114111","volume":"111","author":"S Sun","year":"2014","unstructured":"Sun, S. et al. Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival. Proc. Natl. Acad. Sci. 111, E582\u2013E591 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"69928_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1083\/jcb.151.1.69","volume":"151","author":"RG Gardner","year":"2000","unstructured":"Gardner, R. G. et al. Endoplasmic reticulum degradation requires lumen to cytosol signaling:\u00a0Transmembrane control of Hrd1p by Hrd3p. J. Cell Biol. 151, 69\u201382 (2000).","journal-title":"J. Cell Biol."},{"key":"69928_CR26","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.1073\/pnas.0505014102","volume":"102","author":"BN Lilley","year":"2005","unstructured":"Lilley, B. N. & Ploegh, H. L. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. USA 102, 14296\u201314301 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69928_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45633-0","volume":"15","author":"LL Lin","year":"2024","unstructured":"Lin, L. L. et al. SEL1L-HRD1 interaction is required to form a functional HRD1 ERAD complex. Nat. Commun. 15, 1440 (2024).","journal-title":"Nat. Commun."},{"key":"69928_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1172\/JCI94771","volume":"127","author":"G Shi","year":"2017","unstructured":"Shi, G. et al. ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis. J. Clin. Invest. 127, 556\u2013564 (2017).","journal-title":"J. Clin. Invest."},{"key":"69928_CR29","doi-asserted-by":"crossref","unstructured":"Kim, G. H. et al. Hypothalamic ER-associated degradation regulates POMC maturation, feeding, and age-associated obesity. J. Clin. Invest. 128, 1125\u20131140 (2018).","DOI":"10.1172\/JCI96420"},{"key":"69928_CR30","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1172\/JCI134874","volume":"130","author":"N Shrestha","year":"2020","unstructured":"Shrestha, N. et al. Sel1L-Hrd1 ER-associated degradation maintains \u03b2 cell identity via TGF-\u03b2 signaling. J. Clin. Invest. 130, 3499\u20133510 (2020).","journal-title":"J. Clin. Invest."},{"key":"69928_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163584","volume":"133","author":"N Shrestha","year":"2023","unstructured":"Shrestha, N. et al. Integration of ER protein quality control mechanisms defines beta cell function and ER architecture. J. Clin. Invest 133, e163584 (2023).","journal-title":"J. Clin. Invest"},{"key":"69928_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2337\/db18-0624","volume":"68","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. Endoplasmic reticulum-associated degradation (ERAD) has a critical role in supporting glucose-stimulated insulin secretion in pancreatic beta-cells. Diabetes 68, 733\u2013746 (2019).","journal-title":"Diabetes"},{"key":"69928_CR33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2337\/db19-1060","volume":"69","author":"T Wu","year":"2020","unstructured":"Wu, T. et al. HRD1, an Important Player in Pancreatic beta-Cell Failure and Therapeutic Target for Type 2 Diabetic Mice. Diabetes 69, 940\u2013953 (2020).","journal-title":"Diabetes"},{"key":"69928_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","volume":"25","author":"AP Chambers","year":"2017","unstructured":"Chambers, A. P. et al. The role of pancreatic preproglucagon in glucose homeostasis in mice. Cell Metab. 25, 927\u2013934.e923 (2017).","journal-title":"Cell Metab."},{"key":"69928_CR35","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","volume":"25","author":"ED Dean","year":"2017","unstructured":"Dean, E. D. et al. Interrupted glucagon signaling reveals hepatic \u03b1 cell axis and role for L-glutamine in \u03b1 cell proliferation. Cell Metab. 25, 1362\u20131373.e1365 (2017).","journal-title":"Cell Metab."},{"key":"69928_CR36","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cmet.2017.05.006","volume":"25","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Amino acid transporter slc38a5 controls glucagon receptor inhibition-induced pancreatic \u03b1 cell hyperplasia in mice. Cell Metab. 25, 1348\u20131361.e1348 (2017).","journal-title":"Cell Metab."},{"key":"69928_CR37","first-page":"126","volume":"13","author":"C Shiota","year":"2017","unstructured":"Shiota, C. et al. Gcg (CreERT2) knockin mice as a tool for genetic manipulation in pancreatic alpha cells. Diabetologia 13, 126\u2013110 (2017).","journal-title":"Diabetologia"},{"key":"69928_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213X-1-4","volume":"1","author":"S Srinivas","year":"2001","unstructured":"Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).","journal-title":"BMC Dev. Biol."},{"key":"69928_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.139.3.625","volume":"139","author":"L Muller","year":"1997","unstructured":"Muller, L., Zhu, X. & Lindberg, I. Mechanism of the Facilitation of PC2 Maturation by 7B2: Involvement in ProPC2 Transport and Activation but Not Folding.  J. Cell Biol. 139, 625\u2013638 (1997).","journal-title":"J. Cell Biol."},{"key":"69928_CR40","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1073\/pnas.94.13.6646","volume":"94","author":"M Furuta","year":"1997","unstructured":"Furuta, M. et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. 94, 6646\u20136651 (1997).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"69928_CR41","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1210\/en.2008-0064","volume":"149","author":"S-N Lee","year":"2008","unstructured":"Lee, S.-N. & Lindberg, I. 7B2 prevents unfolding and aggregation of prohormone convertase 2. Endocrinology 149, 4116\u20134127 (2008).","journal-title":"Endocrinology"},{"key":"69928_CR42","doi-asserted-by":"publisher","first-page":"27197","DOI":"10.1074\/jbc.M103362200","volume":"276","author":"M Furuta","year":"2001","unstructured":"Furuta, M. et al. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice.  J. Biol. Chem. 276, 27197\u201327202 (2001).","journal-title":"J. Biol. Chem."},{"key":"69928_CR43","doi-asserted-by":"publisher","first-page":"42504","DOI":"10.1074\/jbc.M111.281980","volume":"286","author":"M Helwig","year":"2011","unstructured":"Helwig, M. et al. Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis. J. Biol. Chem. 286, 42504\u201342513 (2011).","journal-title":"J. Biol. Chem."},{"key":"69928_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0167-0115(02)00207-0","volume":"110","author":"Q-L Li","year":"2003","unstructured":"Li, Q.-L. et al. Prohormone convertase 2 enzymatic activity and its regulation in neuro-endocrine cells and tissues. Regulatory Pept. 110, 197\u2013205 (2003).","journal-title":"Regulatory Pept."},{"key":"69928_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1096\/fj.03-1210fje","volume":"18","author":"C Zuber","year":"2004","unstructured":"Zuber, C., Fan, J.-Y., Guhl, B. & Roth, J. Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J. 18, 917\u2013919 (2004).","journal-title":"FASEB J."},{"key":"69928_CR46","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00125-007-0816-8","volume":"50","author":"P Marchetti","year":"2007","unstructured":"Marchetti, P. et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50, 2486\u20132494 (2007).","journal-title":"Diabetologia"},{"key":"69928_CR47","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.15252\/embr.201643426","volume":"18","author":"J Jacquemyn","year":"2017","unstructured":"Jacquemyn, J., Cascalho, A. & Goodchild, R. E. The ins and outs of endoplasmic reticulum-controlled lipid biosynthesis. EMBO Rep. 18, 1905\u20131921 (2017).","journal-title":"EMBO Rep."},{"key":"69928_CR48","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2337\/db11-1605","volume":"62","author":"C Longuet","year":"2013","unstructured":"Longuet, C. et al. Liver-specific disruption of the murine glucagon receptor produces \u03b1-cell hyperplasia: evidence for a circulating \u03b1-cell growth factor. Diabetes 62, 1196\u20131205 (2013).","journal-title":"Diabetes"},{"key":"69928_CR49","first-page":"16","volume":"2016","author":"E Larger","year":"2016","unstructured":"Larger, E. et al. Pancreatic alpha-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation. Endocrinol. Diab Metab. Case Rep. 2016, 16\u20130081 (2016).","journal-title":"Endocrinol. Diab Metab. Case Rep."},{"key":"69928_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/dom.13075","volume":"20","author":"A Kostic","year":"2018","unstructured":"Kostic, A. et al. A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers. Diab Obes. Metab. 20, 283\u2013291 (2018).","journal-title":"Diab Obes. Metab."},{"key":"69928_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ebiom.2015.03.012","volume":"2","author":"L Marroqui","year":"2015","unstructured":"Marroqui, L. et al. Pancreatic \u03b1 cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes. EBioMedicine 2, 378\u2013385 (2015).","journal-title":"EBioMedicine"},{"key":"69928_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107894","volume":"32","author":"NC Leite","year":"2020","unstructured":"Leite, N. C. et al. Modeling type 1 diabetes in vitro using human pluripotent stem cells. Cell Rep. 32, 107894 (2020).","journal-title":"Cell Rep."},{"key":"69928_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105056","volume":"25","author":"E Bosi","year":"2022","unstructured":"Bosi, E., Marchetti, P., Rutter, G. A. & Eizirik, D. L. Human alpha cell transcriptomic signatures of types 1 and 2 diabetes highlight disease-specific dysfunction pathways. Iscience 25, 105056 (2022).","journal-title":"Iscience"},{"key":"69928_CR54","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1128\/MCB.22.11.3864-3874.2002","volume":"22","author":"P Zhang","year":"2002","unstructured":"Zhang, P. et al. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol. Cell. Biol. 22, 3864\u20133874 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"69928_CR55","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2337\/db12-1747","volume":"62","author":"M Akiyama","year":"2013","unstructured":"Akiyama, M. et al. X-box binding protein 1 is essential for insulin regulation of pancreatic \u03b1-cell function. Diabetes 62, 2439\u20132449 (2013).","journal-title":"Diabetes"},{"key":"69928_CR56","doi-asserted-by":"crossref","unstructured":"Bhattacharya, A. & Qi, L. ER-associated degradation in health and disease - from substrate to organism. J. Cell. Sci. 132 jcs232850 (2019).","DOI":"10.1242\/jcs.232850"},{"key":"69928_CR57","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1172\/JCI90004","volume":"127","author":"N Bozadjieva","year":"2017","unstructured":"Bozadjieva, N. et al. Loss of mTORC1 signaling alters pancreatic \u03b1 cell mass and impairs glucagon secretion. J. Clin. Invest. 127, 4379\u20134393 (2017).","journal-title":"J. Clin. Invest."},{"key":"69928_CR58","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1152\/ajpendo.00022.2013","volume":"305","author":"C Shiota","year":"2013","unstructured":"Shiota, C. et al. \u03b1-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets. Am. J. Physiol. Endocrinol. Metab. 305, E1030\u2013E1040 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"69928_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrn.2018.8","volume":"19","author":"K-S Kim","year":"2018","unstructured":"Kim, K.-S., Seeley, R. J. & Sandoval, D. A. Signalling from the periphery to the brain that regulates energy homeostasis. Nat. Rev. Neurosci.\u00a019, 185\u2013196 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"69928_CR60","doi-asserted-by":"publisher","unstructured":"Torres, M. et al. Purkinje cell-specific deficiency in SEL1L-hrd1 endoplasmic reticulum-associated degradation causes progressive cerebellar ataxia in mice. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.174725 (2024).","DOI":"10.1172\/jci.insight.174725"},{"key":"69928_CR61","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1083\/jcb.129.6.1641","volume":"129","author":"X Zhu","year":"1995","unstructured":"Zhu, X. & Lindberg, I. 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity.  J. Cell Biol. 129, 1641\u20131650 (1995).","journal-title":"J. Cell Biol."},{"key":"69928_CR62","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0092-8674(00)80579-6","volume":"96","author":"CH Westphal","year":"1999","unstructured":"Westphal, C. H. et al. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary cushing\u2019s disease. Cell 96, 689\u2013700 (1999).","journal-title":"Cell"},{"key":"69928_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2007.05.014","volume":"92","author":"TS Leak","year":"2007","unstructured":"Leak, T. S. et al. Association of the proprotein convertase subtilisin\/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population. Mol. Genet Metab. 92, 145\u2013150 (2007).","journal-title":"Mol. Genet Metab."},{"key":"69928_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11033-011-0705-6","volume":"39","author":"X Zheng","year":"2012","unstructured":"Zheng, X. et al. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol. Biol. Rep. 39, 17\u201323 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"69928_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep14380","volume":"5","author":"TJ Chang","year":"2015","unstructured":"Chang, T. J. et al. Genetic polymorphisms of PCSK2 are associated with glucose homeostasis and progression to type 2 diabetes in a Chinese population. Sci. Rep. 5, 14380 (2015).","journal-title":"Sci. Rep."},{"key":"69928_CR66","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.diabres.2017.06.023","volume":"131","author":"A Winters","year":"2017","unstructured":"Winters, A. et al. Functional analysis of PCSK2 coding variants: A founder effect in the Old Order Amish population. Diab Res. Clin. Pract. 131, 82\u201390 (2017).","journal-title":"Diab Res. Clin. Pract."},{"key":"69928_CR67","doi-asserted-by":"crossref","unstructured":"Campbell, S. A. et al. Human islets contain a subpopulation of glucagon-like peptide-1 secreting \u03b1 cells that is increased in type 2 diabetes. Mol. Metab., 39, 101014 (2020).","DOI":"10.1016\/j.molmet.2020.101014"},{"key":"69928_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.934775","volume":"13","author":"MM Holter","year":"2022","unstructured":"Holter, M. M., Saikia, M. & Cummings, B. P. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion. Front. Endocrinol. 13, 934775 (2022).","journal-title":"Front. Endocrinol."},{"key":"69928_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1369\/00221554241274879","volume":"72","author":"G Teitelman","year":"2024","unstructured":"Teitelman, G. A controversy regarding the identity of the enzyme that mediates glucagon-like peptide 1 synthesis in human alpha cells. J. Histochem. Cytochem. 72, 545\u2013550 (2024).","journal-title":"J. Histochem. Cytochem."},{"key":"69928_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0014-5793(97)00892-2","volume":"413","author":"Y Rouille","year":"1997","unstructured":"Rouille, Y., Bianchi, M., Irminger, J. C. & Halban, P. A. Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon. Febs Lett. 413, 119\u2013123 (1997).","journal-title":"Febs Lett."},{"key":"69928_CR71","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db11-0876","volume":"60","author":"F Thorel","year":"2011","unstructured":"Thorel, F. et al. Normal glucagon signaling and \u03b2-cell function after near-total \u03b1-cell ablation in adult mice. Diabetes 60, 2872\u20132882 (2011).","journal-title":"Diabetes"},{"key":"69928_CR72","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0026-0495(80)90014-1","volume":"29","author":"V Bonnevie-Nielsen","year":"1980","unstructured":"Bonnevie-Nielsen, V. Experimental diets affect pancreatic insulin and glucagon differently in male and female mice. Metabolism 29, 386\u2013391 (1980).","journal-title":"Metabolism"},{"key":"69928_CR73","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad099","volume":"7","author":"S Jo","year":"2023","unstructured":"Jo, S. et al. Sex differences in pancreatic \u03b2-cell physiology and glucose homeostasis in C57BL\/6J Mice. J. Endocr. Soc. 7, bvad099 (2023).","journal-title":"J. Endocr. Soc."},{"key":"69928_CR74","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s004280000374","volume":"438","author":"Z Ling","year":"2001","unstructured":"Ling, Z. et al. Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Arch. 438, 382\u2013387 (2001).","journal-title":"Virchows Arch."},{"key":"69928_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44948-2","volume":"15","author":"X Wei","year":"2024","unstructured":"Wei, X. et al. Proteomic screens of SEL1L-HRD1 ER-associated degradation substrates reveal its role in glycosylphosphatidylinositol-anchored protein biogenesis. Nat. Commun. 15, 659 (2024).","journal-title":"Nat. Commun."},{"key":"69928_CR76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170054","volume":"134","author":"HH Wang","year":"2023","unstructured":"Wang, H. H. et al. Hypomorphic variants of SEL1L-HRD1 ER-associated degradation are associated with neurodevelopmental disorders. J. Clin. Investig. 134, e170054 (2023).","journal-title":"J. Clin. Investig."},{"key":"69928_CR77","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2337\/db19-0058","volume":"68","author":"KH Kaestner","year":"2019","unstructured":"Kaestner, K. H., Powers, A. C., Naji, A., Consortium, H. & Atkinson, M. A. NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the human pancreas analysis program (HPAP). Diabetes 68, 1394\u20131402 (2019).","journal-title":"Diabetes"},{"key":"69928_CR78","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.cmet.2022.09.013","volume":"34","author":"SN Shapira","year":"2022","unstructured":"Shapira, S. N., Naji, A., Atkinson, M. A., Powers, A. C. & Kaestner, K. H. Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: the human pancreas analysis program. Cell Metab. 34, 1906\u20131913 (2022).","journal-title":"Cell Metab."},{"key":"69928_CR79","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2337\/dbi19-0019","volume":"68","author":"M Brissova","year":"2019","unstructured":"Brissova, M. et al. The integrated islet distribution program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles. Diabetes 68, 1363\u20131365 (2019).","journal-title":"Diabetes"},{"key":"69928_CR80","doi-asserted-by":"publisher","DOI":"10.3791\/57931","author":"Y Kong","year":"2018","unstructured":"Kong, Y., Ebrahimpour, P., Liu, Y., Yang, C. & Alonso, L. C. Pancreatic islet embedding for paraffin sections. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57931 (2018).","journal-title":"J. Vis. Exp."},{"key":"69928_CR81","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00125-011-2369-0","volume":"55","author":"C Dai","year":"2012","unstructured":"Dai, C. et al. Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets. Diabetologia 55, 707\u2013718 (2012).","journal-title":"Diabetologia"},{"key":"69928_CR82","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.2337\/diabetes.53.5.1318","volume":"53","author":"M Brissova","year":"2004","unstructured":"Brissova, M. et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53, 1318\u20131325 (2004).","journal-title":"Diabetes"},{"key":"69928_CR83","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1242\/dev.098657","volume":"141","author":"RB Reinert","year":"2014","unstructured":"Reinert, R. B. et al. Vascular endothelial growth factor coordinates islet innervation via vascular scaffolding. Development 141, 1480\u20131491 (2014).","journal-title":"Development"},{"key":"69928_CR84","first-page":"294","volume":"80","author":"L Scopsi","year":"1995","unstructured":"Scopsi, L., Gullo, M., Rilke, F., Martin, S. & Steiner, D. F. Proprotein convertases (PC1\/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J. Clin. Endocrinol. Metab. 80, 294\u2013301 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"69928_CR85","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1074\/jbc.273.18.11107","volume":"273","author":"A Zhou","year":"1998","unstructured":"Zhou, A., Martin, S., Lipkind, G., LaMendola, J. & Steiner, D. F. Regulatory roles of the P domain of the subtilisin-like prohormone convertases. J. Biol. Chem. 273, 11107\u201311114 (1998).","journal-title":"J. Biol. Chem."},{"key":"69928_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1677\/jme.0.0270107","volume":"27","author":"M Blazquez","year":"2001","unstructured":"Blazquez, M., Docherty, K. & Shennan, K. I. Association of prohormone convertase 3 with membrane lipid rafts. J. Mol. Endocrinol. 27, 107\u2013116 (2001).","journal-title":"J. Mol. Endocrinol."},{"key":"69928_CR87","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41590-019-0396-z","volume":"20","author":"Y Ji","year":"2019","unstructured":"Ji, Y. et al. Toll-like receptors TLR2 and TLR4 block the replication of pancreatic \u03b2 cells in diet-induced obesity. Nat. Immunol. 20, 677\u2013686 (2019).","journal-title":"Nat. Immunol."},{"key":"69928_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04456-4","volume":"7","author":"N Okita","year":"2017","unstructured":"Okita, N. et al. Modified Western blotting for insulin and other diabetes-associated peptide hormones. Sci. Rep. 7, 6949 (2017).","journal-title":"Sci. Rep."},{"key":"69928_CR89","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2009.04.009","volume":"9","author":"H Sha","year":"2009","unstructured":"Sha, H. et al. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab. 9, 556\u2013564 (2009).","journal-title":"Cell Metab."},{"key":"69928_CR90","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69928-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:21:09Z","timestamp":1775622069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69928-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69928"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69928-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3202"}}